Evidence map›Paper›PMID 24638111›Full record

ArticlePloS one2014

Complement C4 deficiency--a plausible risk factor for non-tuberculous mycobacteria (NTM) infection in apparently immunocompetent patients.

Hannele Kotilainen, Marja-Liisa Lokki, Riitta Paakkanen, Mikko Seppänen, Pentti Tukiainen, Seppo Meri, Tuija Poussa, Jussi Eskola, Ville Valtonen, Asko Järvinen

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Trial
  2. Observational
  3. Article
  4. Pulmonary non-tuberculous mycobacterial infections: current state and future management.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2020
    Review
  5. Article
  6. Article
  7. Clinical findings in relation to mortality in non-tuberculous mycobacterial infections: patients with Mycobacterium avium complex have better survival than patients with other mycobacteria.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2015
    Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Hannele KotilainenDivision of Infectious Diseases, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland.
Marja-Liisa LokkiTransplantation Laboratory, Haartman Institute, University of Helsinki, Helsinki, Finland.
Riitta PaakkanenTransplantation Laboratory, Haartman Institute, University of Helsinki, Helsinki, Finland; Division of Cardiology, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland.
Mikko SeppänenDivision of Infectious Diseases, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland.
Pentti TukiainenDivision of Lung Diseases, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland.
Seppo MeriDepartment of Bacteriology and Immunology, Haartman Institute, University of Helsinki, Helsinki, Finland.
Tuija PoussaSTAT-Consulting, Nokia, Finland.
Jussi EskolaMycobacteriology Unit, Helsinki University Central Hospital Laboratory, Helsinki, Finland.
Ville ValtonenDivision of Infectious Diseases, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland.
Asko JärvinenDivision of Infectious Diseases, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland.
Helsinki University Hospital · FIUniversity of Helsinki · FINokia (Finland) · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNon-tuberculous mycobacteria (NTM) are ubiquitous in the environment and they infect mainly persons with underlying pulmonary diseases but also previously healthy elderly women. Defects in host resistance that lead to pulmonary infections by NTM are relatively unknown. A few genetic defects have been associated with both pulmonary and disseminated mycobacterial infections. Rare disseminated NTM infections have been associated with genetic defects in T-cell mediated immunity and in cytokine signaling in families. We investigated whether there was an association between NTM infections and deficiencies of complement components C4A or C4B that are encoded by major histocompatibility complex (MHC).

methods50 adult patients with a positive NTM culture with symptoms and findings of a NTM disease were recruited. Patients' clinical history was collected and symptoms and clinical findings were categorized according to 2007 diagnostic criteria of The American Thoracic Society (ATS). To investigate the deficiencies of complement, C4A and C4B gene copy numbers and phenotype frequencies of the C4 allotypes were analyzed. Unselected, healthy, 149 Finnish adults were used as controls.

resultsNTM patients had more often C4 deficiencies (C4A or C4B) than controls (36/50 [72%] vs 83/149 [56%], OR = 2.05, 95%CI = 1.019-4.105, p = 0.042). C4 deficiencies for female NTM patients were more common than for controls (29/36 [81%] vs 55/100 [55%], OR = 3.39, 95% CI = 1.358-8.460, p = 0.007). C4 deficiences seemed not to be related to any specific underlying disease or C4 phenotype.

conclusionsC4 deficiency may be a risk factor for NTM infection in especially elderly female patients.

Indexed as

AgedAged, 80 and overCase-Control StudiesComplement C4Disease SusceptibilityFemaleFinlandGenotypeHumansMaleMiddle AgedMycobacterium Infections, NontuberculousNontuberculous MycobacteriaPhenotypeRisk FactorsComplement C4

Identifiers

PMID24638111
PMCPMC3956671
OpenAlexW1982321827

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.